Campbell & Co Investment Adviser’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
MGP
AIM
Campbell & Co Investment Adviser's DGX Position: Q2 2026 in Review
Campbell & Co Investment Adviser increased its Quest Diagnostics (DGX) stake by 526% in Q2 2026, buying an estimated $3.61M and bringing the position to 21,872 shares worth $4.64M. The position accounts for 0.24% of the portfolio, ranked #94.
Campbell & Co Investment Adviser first reported a position in DGX in Q4 2013 and has held it in 16 quarters since. 629 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Campbell & Co Investment Adviser held 21,872 shares of Quest Diagnostics worth $4.64M as of Q2 2026.
- Campbell & Co Investment Adviser bought 18,376 Quest Diagnostics shares in Q2 2026, an estimated $3.61M.
- Quest Diagnostics made up 0.24% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #94 holding.
- Campbell & Co Investment Adviser first reported a position in Quest Diagnostics in Q4 2013 and has held it in 16 quarters since.
- 629 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.